Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-09Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy
-
CLINICAL_TRIALS study record update · 2026-01-09Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-01-08A First-in-patient Phase I/II Clinical Study to Investigate the Safety, Tolerability and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Subjects With Severe Complications of Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-01-07Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain: Promoting Engagement in Cognitive Behavioral Therapy
-
CLINICAL_TRIALS study record update · 2026-01-07Assessing Combination Hydroxyurea and Exogenous Erythropoietin in Sickle Cell Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-05Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
-
CLINICAL_TRIALS study record update · 2026-01-05A Pilot Study of Nonmyeloablative Regimen Using Total Marrow and Lymphoid Irradiation for Irradiation Sparing of Bystander Organs in Hematopoietic Cell Transplantation From Matched Related or Unrelated Donor in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-01-02A Study to Assess the Effect of Etavopivat on Cardiac Repolarisation in Healthy Participants
-
CLINICAL_TRIALS study record update · 2025-12-31An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)
-
CLINICAL_TRIALS study record update · 2025-12-30A Multicentre Trial Evaluating the Efficacy and Safety of Oral Decitabine Tetrahydrouridine (NDec) in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-29A Single-centre, Open-label, Single-group Study Investigating the Pharmacokinetics, Safety and Tolerability After a Single Dose of Oral Etavopivat in Healthy Chinese Participants
-
CLINICAL_TRIALS study record update · 2025-12-24Pilot Study to Investigate the Use of Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
-
CLINICAL_TRIALS study record update · 2025-12-19Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-19Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-19Integrative Training Program for Pediatric Sickle Cell Pain (I-STRONG for SCD): Optimizing Feasibility and Acceptability
-
CLINICAL_TRIALS study record update · 2025-12-19Non-myeloablative Phase I/II Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
-
CLINICAL_TRIALS study record update · 2025-12-17Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
-
CLINICAL_TRIALS study record update · 2025-12-17An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients With Sickle Cell Disease and Severe Vaso-Occlusive Crises (Beacon Trial)
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-15A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Determine Efficacy and Safety of SIL-8301 in Sickle Cell Disease (SCD) Patients With a Predominantly Hemolytic Phenotype
-
CLINICAL_TRIALS study record update · 2025-12-12A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-10Study of Lipid Balance in Adult Sickle Cell SS or SC Patients at Steady State and According to Clinical Phenotypes and During Acute Complications Acronym : "HDL2"
-
CLINICAL_TRIALS study record update · 2025-12-10Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-12-09Prevention of Malnutrition in Children With Sickle Cell Disease Living in Northern Nigeria